Michael Kramer

Michael Kramer

Michael Kramer is the Founder of Mott Capital Management and runs MCM's actively managed long-only Thematic Growth Portfolio which holds these stocks: ACAD, ALKS, CELG, DEO, DIS, GE, GOOGL, MA, MO, NFLX, NXPI, RTN, SBUX, SWKS TSKA, UL, V, VOD and VZ.

Additionally, he is the premium author of Reading The Market an exclusive offering on Seeking Alpha's marketplace.  

Michael's professional skills, first honed in high-risk trading environments, have now matured into a comprehensive, in-depth financial analysis of public companies, with a particular focus on finding new generational themes and trends in society. Additionally, he has dedicated a significant amount of his research to global macro economics and Central Bank policies impact on financial markets. 

  • Showing 751-753 of 753 items
  • <<
  • ...
  • 49
  • 50
  • 51
  1. Stocks

    Is the Johnson & Johnson Bid for Actelion a Growth Play? (JNJ)

    Both Johnson & Johnson and Actelion have recently confirmed they are both in preliminary acquisition talks.
  2. Stocks

    Eli Lilly's Drug Solanezumab Failed In A Key Alzheimer's Disease Trial (LLY, BIIB)

    Eli Lilly & Co. reported that topline results for its phase III trial for Solanezumab, a monoclonal antibody, failed ...
  3. Stocks

    Merck Announces Dividend Increase, Offering Attractive Yield (MRK)

    On November 22nd, 2016 Merck announced it was increasing it dividend.
  • Showing 751-753 of 753 items
  • <<
  • ...
  • 49
  • 50
  • 51